Insider · CIK 0001451038
Tanya Lewis
Files at DMAC (DiaMedica Therapeutics Inc.). First filing -, latest -.
Tanya Lewis files SEC Form 4 as director at DMAC (DiaMedica Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tanya Lewis has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +40,412 | $0.00 | $0 | 40,412 | Jun 3, 2026 |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +32,162 | $0.00 | $0 | 32,162 | Jun 3, 2025 |
Questions about Tanya Lewis
Answered from the filings on this page, as of the latest one.
Is Tanya Lewis buying or selling?
Tanya Lewis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tanya Lewis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tanya Lewis has 0.
Where does Tanya Lewis file Form 4?
Tanya Lewis has filed Form 4 at DMAC (DiaMedica Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.